Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance

Alimentary Pharmacology & Therapeutics
Y E ChonDo Young Kim

Abstract

A proportion of chronic hepatitis B (CHB) patients are diagnosed with advanced hepatocellular carcinoma (HCC) despite regular surveillance. To determine predictors for HCC detection failure in CHB patients who underwent regular surveillance. CHB patients with well-preserved liver function, who underwent ultrasonography and alpha-foetoprotein (AFP) analysis every 6 months, were enrolled. Cox regression analysis was used to identify predictors for detection failure, defined as HCC initially diagnosed at Barcelona Clinic Liver Cancer (BCLC) stage B or C. Of the 4590 CHB patients (mean age, 52.1 years; men, 61.6%), 169 patients were diagnosed with HCC (3.68%) and 35 (20.7%) HCC patients were initially diagnosed with HCC BCLC stage B or C. The cumulative incidence of HCC detection failure was 0.2% at year 1 and 1.3% at year 5. Multivariate analyses indicated that cirrhosis (hazard ratio [HR], 3.078; 95% CI, 1.389-6.821; P = 0.006), AFP levels ≥9 ng/mL (HR, 5.235; 95% CI, 2.307-11.957; P = 0.010), and diabetes mellitus (HR, 3.336; 95% CI, 1.341-8.296; P = 0.010) were independent predictors of HCC detection failure. Another model that incorporated liver stiffness (LS) values identified LS values ≥11.7 kPa (HR, 11.045; 95% CI, 2.066-59...Continue Reading

References

Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H OkaK Kobayashi
Nov 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K KobayashiN Hattori
Mar 14, 1996·The New England Journal of Medicine·V MazzaferroL Gennari
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Oct 13, 1999·Seminars in Liver Disease·J M LlovetJ Bruix
Feb 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R LeroseE Villa
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Manal M HassanYehuda Z Patt
Dec 31, 2003·Ultrasound in Medicine & Biology·Laurent SandrinRobert Palau
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Mar 24, 2005·Intervirology·Kwang-Hyub Han, Sang Hoon Ahn
Jun 18, 2005·World Journal of Gastroenterology : WJG·Linda-L WongRichard Severino
Jul 14, 2005·Journal of Computer Assisted Tomography·Bachir TaouliFergus V Coakley
Jan 13, 2006·The American Journal of Gastroenterology·Maria Chiara CantariniUNKNOWN Italian Liver Cancer (ITA.LI.CA) group
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Feb 20, 2009·Oncology·Soo Ryang KimUNKNOWN Organizing Committee of Japan-Korea Liver Symposium
Feb 18, 2009·Journal of Gastroenterology and Hepatology·Man-Fung YuenUNKNOWN Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma
May 2, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Al B BensonAndrew X Zhu
Jun 26, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jessica A DavilaHashem B El-Serag
Oct 6, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Nam C YuDavid S K Lu
Dec 9, 2010·The Oncologist·Arun J SanyalRiccardo Lencioni
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
May 24, 2011·Journal of Clinical Gastroenterology·Amit G SingalJorge A Marrero
Jan 5, 2012·Journal of General Internal Medicine·Amit G SingalJasmin A Tiro
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Jun 12, 2012·BMC Gastroenterology·Spiros P HiotisHerman T Yee
Aug 1, 2012·Cancer Prevention Research·Amit G SingalJasmin A Tiro
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C VerslypeUNKNOWN ESMO Guidelines Working Group
Jan 23, 2013·The American Journal of Gastroenterology·Amit G SingalWilliam M Lee
Sep 14, 2013·Liver International : Official Journal of the International Association for the Study of the Liver·Young Eun ChonKwang-Hyub Han
Jan 28, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Norihiro KokudoMasatoshi Makuuchi
Apr 15, 2015·The American Journal of Gastroenterology·Te-Sheng ChangYen-Hua Huang
Apr 29, 2015·Gut and Liver·UNKNOWN Korean Liver Cancer Study Group (KLCSG), UNKNOWN National Cancer Center, Korea (NCC)
Jan 20, 2016·Alimentary Pharmacology & Therapeutics·M WalkerF Kanwal

❮ Previous
Next ❯

Citations

May 4, 2021·Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes·Lauren KiriSharon E Clarke
May 1, 2021·Clinics and Research in Hepatology and Gastroenterology·Laurent LamUNKNOWN ANRS/AFEF Hepather study group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.